Chiltern has acquired Japanese CRO Integrated Development Associates (IDA), strengthening its presence in Asia.

Eisai and partner Charles River have clearly enjoyed their two-year R&D deal, as the pharma-CRO pair have signed up to extend that partnership for another…

Medrio, which focuses on electronic data capture, just got its first equity boost from an institutional investor—$30 million from Questa Capital Management.

Worldwide Clinical Trials appointed Karen Nowatkoski as VP of clinical operations and site management to oversee the clinical operations team, including…

PPD has expanded its vaccine sciences lab in Richmond, Virginia, by another 17,000 square feet and added vaccine efficacy testing capacity using cell-based…

Charles River Laboratories has beefed up its library of patient-derived xenografts (PDXs) by adding new genetic characteristics into the mix.

DelMar is advancing its first-in-class brain cancer med dianhydrogalactitol (VAL-083) into phase 3, and it has recruited PRA Health Sciences to conduct that…

China's FDA is proposing new policies to hasten clinical trial approval and lift restrictions placed on trial sites.

CRO